XRCC5 and neoplasm: While not confirming the Moeller results in detail, our data also show profound differences in patient survival in dependence of Ku80 expression when using an alternative scoring system to identify patients with particularly low expression levels, namely those showing no or only faint Ku80 staining intensity in the majority (≥ 70%) of tumor cells.